BBIO

BridgeBio Pharma, Inc.

35.95 USD
+1.80 (+5.27%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

BridgeBio Pharma, Inc. stock is up 4.84% since 30 days ago. The next earnings date is May 2, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 60% of the previous 4 March’s closed higher than February. In the last 10 Unusual Options Trades, there were 8 CALLs, 2 PUTs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
20 Feb 15:58 16 Aug, 2024 35.00 CALL 85 5
20 Feb 15:58 16 Aug, 2024 45.00 CALL 85 24
20 Feb 16:00 16 Aug, 2024 45.00 CALL 64 24
20 Feb 16:00 17 May, 2024 35.00 CALL 64 2344
20 Feb 16:00 16 Aug, 2024 35.00 CALL 64 5
20 Feb 18:32 17 May, 2024 35.00 CALL 64 2344
21 Feb 15:06 17 May, 2024 35.00 PUT 500 1145
21 Feb 15:49 19 Apr, 2024 35.00 CALL 500 4
21 Feb 19:38 17 May, 2024 35.00 PUT 500 1145
27 Feb 19:40 17 May, 2024 25.00 CALL 48 179

About BridgeBio Pharma, Inc.

BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a stabilizer of transthyretin, or TTR.